Cargando…
Larotrectinib treatment for infantile fibrosarcoma in newborns: a case report and literature review
Infantile fibrosarcoma (IFS) is a rare tumor in childhood characterized by a single, localized, painless mass that grows rapidly but has a relatively indolent biological behavior and a favorable prognosis. Eighty-five percent of infantile fibrosarcomas are associated with t (12;15) (p13;25) chromoso...
Autores principales: | Wang, Dandan, Zhang, Fanhui, Feng, Wanli, Pan, Jiarong, Yuan, Tianming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412926/ https://www.ncbi.nlm.nih.gov/pubmed/37576877 http://dx.doi.org/10.3389/fonc.2023.1206833 |
Ejemplares similares
-
Larotrectinib as an Effective Therapy in Congenital Infantile Fibrosarcoma: Report of Two Cases
por: Lapeña, Lucas Moratilla, et al.
Publicado: (2022) -
Limb salvage of an infant with infantile fibrosarcoma using TRK inhibitor larotrectinib
por: Sahni, Shubham, et al.
Publicado: (2023) -
Infantile Fibrosarcoma of the Bone: A Case Report and Literature Review
por: Tfayli, Yehia, et al.
Publicado: (2023) -
Congenital Infantile Fibrosarcoma Causing Intestinal Perforation in a Newborn
por: Kaiser, Margarita, et al.
Publicado: (2017) -
Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion
por: Bielack, S S, et al.
Publicado: (2019)